
Baseline fecal tryptophan metabolites can predict dietary therapy outcomes in pediatric Crohn’s disease (CD). Higher kynurenine levels were associated with no remission in both CDED+PEN and EEN groups. The strongest predictors of remission were tryptophan-metabolite ratios, with the serotonin/kynurenine ratio showing a perfect AUC of 1 for CDED+PEN. These findings suggest that fecal tryptophan-metabolite markers could personalize dietary interventions for pediatric CD, improving treatment outcomes.
Like
Save
Share